Cargando…

TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG

Lung adenocarcinoma (LUAD) is the most common form of lung cancer and with the highest mortality rate. Therefore, the identification and development of effective methods for the treatment of LUAD is of great importance. The present study aimed to investigate the role of thioredoxin domain-containing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, Pan, Xiaotao, Li, Jie, Zhao, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073845/ https://www.ncbi.nlm.nih.gov/pubmed/35485284 http://dx.doi.org/10.3892/mmr.2022.12719

Ejemplares similares

Knockdown of TXNDC9 induces apoptosis and autophagy in glioma and mediates cell differentiation by p53 activation
por: Zheng, Tingting, et al.
Publicado: (2020)

Curcumenol Targeting YWHAG Inhibits the Pentose Phosphate Pathway and Enhances Antitumor Effects of Cisplatin
por: Mao, Zhijie, et al.
Publicado: (2022)

TXNDC12 inhibits lipid peroxidation and ferroptosis
por: Tang, Lanlan, et al.
Publicado: (2023)

Txndc9 Is Required for Meiotic Maturation of Mouse Oocytes
por: Ma, Fanhua, et al.
Publicado: (2017)

TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma
por: Yu, Hao, et al.
Publicado: (2023)

TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network
por: Chen, Dawei, et al.
Publicado: (2018)

Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation
por: Chan, Mikko C., et al.
Publicado: (2021)

YWHAG inhibits influenza a virus replication by suppressing the release of viral M2 protein
por: Mao, Haiying, et al.
Publicado: (2022)

The role and mechanism of TXNDC5 in diseases
por: Wang, Xueling, et al.
Publicado: (2022)

Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis
por: Chang, Xiaotian, et al.
Publicado: (2011)

LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG
por: Chen, Gaoyang, et al.
Publicado: (2021)

Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation
por: Sheng, Li, et al.
Publicado: (2023)

YWHAG Mutations Cause Childhood Myoclonic Epilepsy and Febrile Seizures: Molecular Sub-regional Effect and Mechanism
por: Ye, Xing-Guang, et al.
Publicado: (2021)

Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis
por: Wang, Lin, et al.
Publicado: (2013)

Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway
por: Hexiao, Tang, et al.
Publicado: (2021)

A heterozygous missense variant in the YWHAG gene causing developmental and epileptic encephalopathy 56 in a Chinese family
por: Yi, Zhi, et al.
Publicado: (2022)

YWHAG Deficiency Disrupts the EMT‐Associated Network to Induce Oxidative Cell Death and Prevent Metastasis
por: Lee, Jeannie Xue Ting, et al.
Publicado: (2023)

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

Targeting mechanosensitive endothelial TXNDC5 to stabilize eNOS and reduce atherosclerosis in vivo
por: Yeh, Chih-Fan, et al.
Publicado: (2022)

Knockdown of TTC9 inhibits the proliferation, migration and invasion, but induces the apoptosis of lung adenocarcinoma cells
por: Huang, Xiaoyue, et al.
Publicado: (2022)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)

m(6)A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation
por: Yue, Zhanghui, et al.
Publicado: (2022)

LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer
por: Xu, Jian, et al.
Publicado: (2021)

Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression
por: Shi, Yujia, et al.
Publicado: (2020)

Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway
por: Yang, Chong-Yi, et al.
Publicado: (2021)

Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence
por: Tan, Fengbo, et al.
Publicado: (2018)

Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
por: Liu, Ying-Fu, et al.
Publicado: (2016)

Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p
por: Zang, Hongliang, et al.
Publicado: (2020)

Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
por: Bi, Guoshu, et al.
Publicado: (2021)

Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma
por: Sun, Hong, et al.
Publicado: (2015)

Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014)

TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin
por: Yuan, Kefei, et al.
Publicado: (2019)

TXNDC2 joint molecular marker is associated with testis pathology and is an accurate predictor of sperm retrieval
por: Javadirad, Seyed-Morteza, et al.
Publicado: (2021)

Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
por: Li, Jianjun, et al.
Publicado: (2022)

Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma
por: Wang, Xinzhuang, et al.
Publicado: (2021)

MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
por: Wu, Balu, et al.
Publicado: (2019)

MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
por: Wang, Xing, et al.
Publicado: (2020)

AGTR1 Inhibits the Progression of Lung Adenocarcinoma
por: Xiong, Lecai, et al.
Publicado: (2021)

Knockdown of LINC01614 inhibits lung adenocarcinoma cell progression by up‐regulating miR‐217 and down‐regulating FOXP1
por: Liu, Ai‐Na, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a1dsvp1qtvn8t4q7ub8vr1t79l